drugset

drugset / Trial / NCT00722306

A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers

NCT00722306 ↗

Phase 1 Completed 6 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the mass balance of PD 0200390

Timeline

Start: 2008-05
Primary completion: 2008-05
Completion: 2008-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ATAGABALIN	Small molecule	60 mg	—

Indications